Csenge Advisory Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.8M | Sell |
14,011
-1,161
| -8% | -$136K | 0.07% | 221 |
|
|
2026
Q1 | $1.83M | Buy |
15,172
+2,051
| +16% | +$237K | 0.08% | 195 |
|
|
2025
Q4 | $1.38M | Buy |
13,121
+685
| +6% | +$64.3K | 0.06% | 246 |
|
|
2025
Q3 | $1.04M | Sell |
12,436
-4,220
| -25% | -$348K | 0.05% | 281 |
|
|
2025
Q2 | $1.28M | Buy |
16,656
+232
| +1% | +$18.4K | 0.07% | 226 |
|
|
2025
Q1 | $1.28M | Sell |
16,424
-4,810
| -23% | -$449K | 0.07% | 213 |
|
|
2024
Q4 | $2.11M | Sell |
21,234
-7,078
| -25% | -$730K | 0.11% | 136 |
|
|
2024
Q3 | $3.11M | Sell |
28,312
-1,954
| -6% | -$232K | 0.16% | 113 |
|
|
2024
Q2 | $3.75M | Buy |
30,266
+509
| +2% | +$65.6K | 0.21% | 94 |
|
|
2024
Q1 | $3.93M | Buy |
29,757
+2,442
| +9% | +$301K | 0.22% | 86 |
|
|
2023
Q4 | $2.98M | Buy |
27,315
+607
| +2% | +$63K | 0.19% | 101 |
|
|
2023
Q3 | $2.75M | Sell |
26,708
-2,336
| -8% | -$252K | 0.19% | 100 |
|
|
2023
Q2 | $3.35M | Buy |
29,044
+725
| +3% | +$82.3K | 0.22% | 82 |
|
|
2023
Q1 | $3.01M | Sell |
28,319
-1,883
| -6% | -$203K | 0.22% | 91 |
|
|
2022
Q4 | $3.35M | Buy |
30,202
+350
| +1% | +$35.8K | 0.26% | 76 |
|
|
2022
Q3 | $2.57M | Sell |
29,852
-196
| -0.7% | -$17.5K | 0.21% | 89 |
|
|
2022
Q2 | $2.74M | Buy |
30,048
+7,302
| +32% | +$647K | 0.23% | 87 |
|
|
2022
Q1 | $1.87M | Sell |
22,746
-4,239
| -16% | -$334K | 0.15% | 128 |
|
|
2021
Q4 | $2.1M | Sell |
26,985
-2,525
| -9% | -$201K | 0.19% | 101 |
|
|
2021
Q3 | $2.4M | Buy |
29,510
+2,525
| +9% | +$192K | 0.2% | 91 |
|
|
2021
Q2 | $2.1M | Buy |
26,985
+9,718
| +56% | +$723K | 0.19% | 101 |
|
|
2021
Q1 | $1.26M | Sell |
17,267
-823
| -5% | -$60.7K | 0.13% | 125 |
|
|
2020
Q4 | $1.41M | Buy |
18,090
+499
| +3% | +$38.2K | 0.17% | 100 |
|
|
2020
Q3 | $1.34M | Sell |
17,591
-429
| -2% | -$33.6K | 0.18% | 92 |
|
|
2020
Q2 | $1.33M | Buy |
18,020
+3,428
| +23% | +$258K | 0.19% | 96 |
|
|
2020
Q1 | $1.07M | Sell |
14,592
-1,265
| -8% | -$99.4K | 0.28% | 79 |
|
|
2019
Q4 | $1.38M | Buy |
15,857
+52
| +0.3% | +$4.27K | 0.35% | 55 |
|
|
2019
Q3 | $1.27M | Buy |
15,805
+13,269
| +523% | +$1.06M | 0.35% | 58 |
|
|
2019
Q2 | $203K | Hold |
2,536
| – | – | 0.07% | 185 |
|
|
2019
Q1 | $201K | Sell |
2,536
-969
| -28% | -$72.5K | 0.07% | 187 |
|
|
2018
Q4 | $255K | Buy |
3,505
+1,889
| +117% | +$133K | 0.09% | 151 |
|
|
2018
Q3 | $114K | Sell |
1,616
-6,428
| -80% | -$410K | 0.04% | 219 |
|
|
2018
Q2 | $469K | Sell |
8,044
-1,612
| -17% | -$90.9K | 0.17% | 126 |
|
|
2018
Q1 | $502K | Buy |
9,656
+1,822
| +23% | +$98.4K | 0.17% | 127 |
|
|
2017
Q4 | $421K | Sell |
7,834
-12,503
| -61% | -$693K | 0.15% | 124 |
|
|
2017
Q3 | $1.24M | Buy |
+20,337
| New | +$1.23M | 0.49% | 54 |
|
Other funds holding MRK
Csenge Advisory Group's MRK Position: Q2 2026 in Review
Csenge Advisory Group reduced its Merck (MRK) stake by 7.7% in Q2 2026, selling an estimated $136K and leaving 14,011 shares worth $1.8M. The position accounts for 0.07% of the portfolio, ranked #221.
Csenge Advisory Group first reported a position in MRK in Q3 2017 and has held it in 36 quarters since. The position peaked at $3.93M in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Csenge Advisory Group held 14,011 shares of Merck worth $1.8M as of Q2 2026.
- Csenge Advisory Group sold 1,161 Merck shares in Q2 2026, an estimated $136K.
- Merck made up 0.07% of Csenge Advisory Group's portfolio in Q2 2026, its #221 holding.
- Csenge Advisory Group first reported a position in Merck in Q3 2017 and has held it in 36 quarters since.
- Csenge Advisory Group's Merck position peaked at $3.93M in Q1 2024.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.